Abbreviations
- VCR:
-
vincristine
- VBL:
-
vinblastine
- VDS:
-
vindesine, desacetylvinblastine amide sulfate
- CR:
-
complete response
- PR:
-
partial response
- MR:
-
minimal response
References
Barnett, C. J., Cullinan, G. J., Gerzon, K., Hoying, R. C., Jones, W. E., Newlon, W. M., Poore, G. A., Robinson, R. L., Sweeney, M. J., Todd, G. C.: Structure-activity relationships of dimeric catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate. J. Med. Chem. 21, 88 (1978)
Bensch, K. G., Malawista, S. E.: Microtubule crystals in mammalina cells. J. Cell Biol. 40, 95 (1969)
Blum, R. H., Dawson, D. M.: Vindesine (V) — Phase I study of vinca alkaloid. Proc. Am. Assoc. Cancer Res./Am. Soc. Clin. Oncol. 17, 108 (1976)
Bodey, G. P., Freireich, E. J.: Initial clinical studies of vindesine (desacetyl vinblastine amide sulfate). Proc. Am. Assoc. Cancer Res./Am. Soc. Clin. Oncol. 17, 128 (1976)
Bodey, G. P., Lagakos, S. W., Guitierrez, A. C., et al.: Therapy of advanced squamous carcinoma of the lung: cyclophosphamide versus “COMB”. Cancer 39, 1026–1031 (1977)
Casey, E. B., Jellife, A. M., Lequesne, P. M., Millett, Y. L.: Vincristine neuropathy: Clinical and electrophysiological observations. Brain 96, 69 (1973)
Culp, H. W., Daniels, W. D., McMahon, R. E.: Disposition and tissue levels of (3H) vindesine in rats. Cancer Res. 37, 3053 (1977)
Dentler, W. L., Granett, S., Rosenbaum, J. L.: Ultrastructural localization of the high molecular weight proteins associated with in vitro-assembled brain microtubules. J. Cell Biol. 65, 237 (1975)
Dyke, R. W.: Present status of vindesine safety and efficacy data. In: Proceedings of the International Workshop of Vindesine, July 7, 1978. Stuttgart: Thieme (in press) 1979
Dyke, R. W., Nelson, R. L.: Phase I anti-cancer agents. Vindesine (desacetyl vinblastine amide sulfate). Cancer Treat. Rev. 4, 135 (1977)
Dyke, R. W., Nelson, R. L.: Phase I–II clinical investigation of vindesine (desacetyl vinblastine amide sulfate, DVA). Curr. Chemother. 2, (Abstract 640) (1978)
Einhorn, L. H., Furnas, B.: Combination chemotherapy for disseminated malignant melanoma with DTIC, vincristine, and methyl-CCNU. Cancer Treat. Rep. 61, 881–883 (1977)
Gralla, R. J., Tan, C. T. C., Young, C. W.: Review of Phase-II Studies of vindesine at the Memorial Sloan-Kettering Cancer Center. In: Proceedings of the First International Workshop of Vindesine, July 7, 1978. Stuttgart: Thieme (in press) (1979)
Hargrove, W. W.: Preparation and activities of chemically modified dimeri catharanthus alkaloids. Lloydia 27, 340 (1964)
Himes, R. H., Kersey, R. N., Heller-Bettinger, I., Samson, F. E.: Action of the vinca alkaloids vincristine, vinblastine, and desacetyl vinblastine amide in microtubules in vitro. Cancer Res. 36, 3798 (1976)
Holland, J. F., Adrejczuk, A., Grenspan, E.: Initial clinical and pharmacological studies with vindesine: i. v. bolus versus 24-hrs infusion. Proc. Am. Assoc. Cancer Res. 129 (Abstract) (1978)
Korolkovas, A.: Grundlagen der molekularen Pharmakologie. (Essentials of Molecular Pharmacology). p. 80. Stuttgart: Thieme/Frankfurt: Wiley (1974)
Krivit, W., Hammond, D.: Vindesine: a phase II study by the Childrens Cancer Study Group. Curr. Chemother. 2, 1331 (1978)
Krivit, W., Chilcote, R., Kyesmany, A., Sather, H., Anderson, J., Hammond, D.: Vindesine — Phase III. In: Proceedings of the First International Workshop on Vindesine, July 7, 1978. Stuttgart: Thieme (in press) (1979)
Loeb, E., Hill, J. M., Pardue, A. S., Khan, A., Hill, N. O., King, J. J., Hill, R.: Vindesine, a new vinca alkaloid in the treatment of leukemias and lymphomas. Curr. Chemother. 2, 1334 (1978)
Mathé, G.: Experiences with vindesine at Villejuif. In: Proceedings of the First International Workshop on Vindesine, July 7, 1978 Stuttgart: Thieme (in press) (1979)
Mathé, G., Misset, J. L., De Vassal, F., Hayat, M., Machover, D., Bel Pomme, D., Schwarzenberg, L., Ribaud, P., Musset, H., Jasmin, C.: Phase-II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of myeloid leukemia, lymphosarcoma, and Hodgkin's disease. Absence of cross-resistance with vincristine. Med. Oncol. 3, S21 (Abstract 51) (1977)
Mathé, G., Misset, J. L., De Vassal, F., Hayat, M., Machover, D., Bel Pomme, D., Schwarzenberg, L., Ribaud, P., Musset, M., Jasmin, C.: Phase-II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma, and Hodgkin's disease. Absence of cross-resistance with vincristine. Cancer Treat. Rep. 62, 805 (1978)
Nelson, R. L., Dyke, R. W.: Phase I–II clinical investigation of vindesine (desacetyl vinblastine amide sulfate). Curr. Chemother. 2, 1328 (1978)
Nelson, R. L., Root, M. A., Dyke, R. W., Ahmadzai, S.: Pharmacokinetics of desacetyl vinblastine amide (vindesine) in man. Proc. Am. Assoc. Cancer Res. 17, 30 (1976)
Obrist, R., Paravicini, U., Hartmann, D., Nagel, G., Obrecht, J. P.: Vindesine — A clinical trial with special reference to neurological side effects. In: Proceedings of the International Workshop of Vindesine, July 7, 1978. Stuttgart: Thieme (in press) (1979)
Ochs, S., Worth, R.: Comparison of the block of fast axoplasmic transport in mammalian nerve by vincristine, vinblastine and desacetyl vinblastine amide sulfate (DVA) Am. Assoc. Cancer Res. 16, (Abstracts no. 278 and 70) (1975)
Olmsted, J. B., Borisy, G. G.: Microtubules. Ann. Rev. Biochem. 42, 507 (1973)
Owellen, R. J.: The pharmacokinetics of aromatic ring 3H-vinblastine in humans. Fed. Proc. 34, 808 (1975)
Owellen, R. J., Donigian, D. W., Hartke, C. A., Dickerson, R. M., Kuhar, M. J.: The binding of vinblastine to tubulin and to particulate fractions of mammalian brain. Cancer Res. 34, 3180 (1974)
Owellen, R. J., Hartke, C. A., Dickerson, R. M., Hains, F. O.: Inhibition of tubulin-microtubule polymerization by drugs of the vinca alkaloid class. Cancer Res. 36, 1499 (1976)
Powles, T., Smith, I.: Vindesine in the treatment of breast cancer. In: Proceedings of the First International Workshop of Vindesine, July 7, 1978. Stuttgart: Thieme (in press) (1979)
Retsas, S., Newton, K. A., Westbury, G.: Vindesine as a single agent in the treatment of advanced malignant melanoma. In: Proceedings of the First International Workshop of Vindesine, July 7, 1978 Stuttgart: Thieme (in press) (1979)
Root, M. A., Gerzon, K., Dyke, R. W.: A radioimmunoassay for vinblastine and vincristine. Federation of Analytical Chemistry and Spectroscopy Societies, p. 125, Indianapolis, Indiana (1975)
Rosenthal, S., Kaufman, S.: Vincristine neurotoxicity. Ann. Intern. Med. 80, 733 (1974)
Smith, I. E., Hedley, D. W., Powles, T. J., McElwain, T. J.: Vindesine in the treatment of breast carcinoma, malignant melanoma and other solid tumors. Paper presented at the Sixth Vinca alkaloid symposion, London, October 20, 1978
Soifer, D. (ed): New York Academy of Science Conference on the Biology of Cytoplasmic Microtubules. Ann. NY Acad. Sci. 253, 1 (1975)
Sweeney, M. J., Cullinan, G. J., Poore, G. A., Gerzon, K.: Experimental antitumor activity of vinblastine amides. Proc. Am. Assoc. Cancer Res. 15, 37 (1974)
Tan, C.: Clinical and pharmacokinetic studies of vindesine in 50 children with malignant diseases. Curr. Chemother. 2, 1326 (1978)
Todd, G. C., Gibson, W. R., Griffing, W. J., Morton, D. M.: The preclinical study of desacetyl vinblastine amide. Proc. Am. Assoc. Cancer Res. 16, 70 (1975)
Todd, G. C., Gibson, W. R., Morton, D. M.: Toxicology of vindesine (desacetyl vinblastine amide) in mice, rats, and dogs. J. Toxicol. Environ. Health 1, 843 (1976)
Weiss, H. D., Walker, M. D., Wiernik, P. H.: Neurotoxicity of commonly used antineoplastic agents. N. Engl. J. Med. 291, 75 (1974)
Wilson, L.: Microtubules as drug receptors: Pharmacological properties of microtubules protein. Ann. NY Acad. Sci. 253, 213 (1975)
Young, Ch.: Phase II evaluation of vindesine in patients with advanced cancer. Paper presented at the Sixth Vinca Alkaloid Symposium, London, October 20, 1978
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dyke, R.W., Nelson, R.L. & Brade, W.P. Vindesine a short review of preclinical and first clinical data. Cancer Chemother. Pharmacol. 2, 229–232 (1979). https://doi.org/10.1007/BF00257185
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00257185